Toshiki Ikawa

10PUBLICATIONS
17CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)AcceleratorsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 13, 2026
Trends in hypofractionated radiotherapy use among patients with breast or prostate cancer: a multicenter study in Osaka, Japan.

Toshiki Ikawa, Toshitaka Morishima, Kayo Nakata

|Nov 10, 2025
Trends in radiotherapy use and implementation challenges among patients with cervical cancer: a multicenter study in Osaka, Japan.

Toshiki Ikawa, Toshitaka Morishima, Kayo Nakata

|Nov 10, 2025
Secondary Lower-Body Sarcomas in Cervical Cancer Survivors Following Surgery, Radiotherapy, or Both: A Population-Based Study.

Toshiki Ikawa, Kayo Nakata, Toshitaka Morishima

|Jun 12, 2024
What is the optimal isodose line for stereotactic radiotherapy for single brain metastases using HyperArc?

Tomohiro Sagawa, Toshiki Ikawa, Shingo Ohira

|Mar 27, 2024
Safety and Feasibility of Combining On-Demand Selective Locoregional Treatment with First-Line Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma.

Tasuku Nakabori, Sena Higashi, Yutaro Abe

|Dec 26, 2023
Outcomes in patients with high- and very high-risk localized prostate cancer treated with definitive IMRT and long-term hormone therapy.

Norihiko Kawamura, Takuji Hayashi, Akira Nagahara

Pageof 2

Frequent Collaborators

4 joint publications

Naoyuki Kanayama

3 joint publications

Toshitaka Morishima

3 joint publications

Kayo Nakata

2 joint publications

Kenji Kishimoto